Visual inspection with acetic acid as a cervical cancer test: Accuracy validated using latent class analysis

BMC Medical Research Methodology

Volumn 7, Issue , 2007, Pages

  Gaffikin, Lynne ^a,b   McGrath, John A ^a,c   Arbyn, Marc ^d   Blumenthal, Paul D ^a,e  

^a JHPIEGO   (United States)

^b Evaluation and Research Technologies for Health Incorporated   (United States)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; DIAGNOSTIC AGENT;

ADULT; ARTICLE; BIOPSY; CANCER DIAGNOSIS; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEMALE; GOLD STANDARD; HEALTH CENTER; HUMAN; HUMAN TISSUE; INFORMATION PROCESSING; LATENT STRUCTURE ANALYSIS; MAJOR CLINICAL STUDY; SENSITIVITY AND SPECIFICITY; STANDARD; STATISTICAL MODEL; URBAN AREA; UTERINE CERVIX CANCER; VISUAL INSPECTION WITH ACETIC ACID; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PREDICTIVE VALUE; PRIMARY HEALTH CARE; QUALITY CONTROL; QUESTIONNAIRE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VAGINA SMEAR; VALIDATION STUDY; ZIMBABWE;

ACETIC ACID; ADULT; ANALYSIS OF VARIANCE; BIOPSY; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PRIMARY HEALTH CARE; QUALITY CONTROL; QUESTIONNAIRES; REFERENCE STANDARDS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; ZIMBABWE;

EID: 35348927031     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-7-36     Document Type: Article

References (58)

1. ACOG statement of policy: cervical cancer prevention in low-resource settings. ACOG Executive Board, American College of Obstetricians and Gynecologists, Society of Obstetricians and Gynaecologists of Canada, Central American Federation of Associations and Societies of Obstetrics and Gynecology, Gynaecologic Oncologists of Canada, Society of Canadian Colposcopists, Society of Gynecologic Oncologists, Royal College of Obstetricians and Gynaecologists, Obstet Gynecol 2004 103 3 607 609
2. Cervical cancer screening in developing countries. ME Soler L Gaffikin PD Blumenthal, Prim Care Update Ob Gyns 2000 7 118 123 10.1016/S1068-607X(00) 00032-9 10840215
3. Cervical dysplasia treatment: key issues for developing countries. A Bishop J Sherris VD Tsu M Kilbourne-Brook, Bull Pan Am Health Organ 1996 30 378 86 9041749
4. ShanxiProvince cervical cancer screening study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. J Belinson YL Qiao R Pretorius WH Zhang P Elson L Li QJ Pan C Fischer A Lorincz D Zahniser, Gynecol Oncol 2001 83 439 44 10.1006/gyno.2001.6370 11606114
5. Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. University of Zimbabwe/JHPIEGO Cervical Cancer Project, Lancet 1999 353 9156 869 73 10.1016/S0140-6736(98)07033-0 10093978
6. Evaluation of alternative methods of cervical cancer screening for resource-poor setting. L Denny L Kuhn A Pollack H Wainwright T Wright, Cancer 2000 89 826 833 10.1002/1097-0142(20000815)89:4<826::AID-CNCR15>3.0.CO;2-5 10951346
7. Early detection of cervical cancer through acetic acid application - an aided visual inspection. V Singh A Sehgal A Parashari P Sodhani L Satyanarayana, Singapore Med J 2001 42 351 4 11764051
8. Visual inspection with acetic acid in the early detection of cervical cancer and precursors. R Sankaranarayanan B Shyamalakumary R Wesley N Sreedevi Amma DM Parkin MK Nair, Int J Cancer 1999 80 161 3 10.1002/(SICI)1097- 0215(19990105)80:1<161::AID-IJC28>3.0.CO;2-8 9935247
9. Acetic acid visualization of the cervix to detect cervical dysplasia. L Van Le FF Broekhuizen R Janzer-Steele M Behar T Samter, Obstet Gynecol 1993 81 293 5 8423967
10. Acetic acid visualization of the cervix: an alternative to cytologic screening. E Megevand L Denny K Dehaeck R Soeters B Bloch, Obstet Gynecol 1996 88 383 6 10.1016/0029-7844(96)00189-5 8752244
11. Testing cervicography and cervicoscopy as screening tests for cervical cancer. S Cecchini R Bonardi A Mazotta G Grazzini A Iossa S Ciatto, Tumori 1993 79 22 5 8497916
12. Acetic acid test: a promising screening test for early detection of cervical cancer. ER Rodriguez-Reyes RM Cerda-Flores JM Quinonez-Perez V Velasco-Rodriguez EI Cortes-Gutierrez, Anal Quant Cytol Histol 2002 24 134 6 12102124
13. Initial results from arandomized trial of cervical visual screening in rural south India. R Sankaranarayanan R Rajkumar R Theresa PO Esmy C Mahe KR Bagyalakshmi S Thara L Frappart E Lucas R Muwonge S Shanthakumari D Jeevan TM Subbarao DM Parkin J Cherian, Int J Cancer 2004 109 461 7 10.1002/ijc.11726 14961588
14. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. R Sankaranarayanan R Wesley T Somanathan N Dhakad B Shyamalakumary N Sreedevi Amma MD Parkin M Krishnan Nair, Cancer 1998 83 2150 2156 10.1002/(SICI)1097- 0142(19981115)83:10<2150::AID-CNCR13>3.0.CO;2-0 9827719
15. Accuracy of the Papanicolaou test in xscreening for and follow-up of cervical cytologic abnormalities: a systematic review. K Nanda DC McCrory ER Myers LA Bastian V Hasselblad JD Hickey DB Matchar, Ann Intern Med 2000 132 810 9 10819705
16. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. MF Mitchell D Schottenfeld G Tortolero-Luna SB Cantor R Richards-Kortum, Obstet Gynecol 1998 91 626 31 10.1016/S0029-7844(98)00006-4 9540955
17. Reliability of histopathologic diagnosis of cervical intraepithelial neoplasia. JH Bellina WP Dunlap MA Riopelle, South Med J 1982 75 1 6 8 7054882
18. Observer variability in histopathological reporting of cervical biopsy specimens. AJ Robertson JM Anderson JS Beck RA Burnett SR Howatson FD Lee AM Lessells KM McLaren SM Moss JG Simpson, J Clin Pathol 1998 42 231 8 10.1136/jcp.42.3.231
19. Some issues in resolution of diagnostic tests using an imperfect gold standard. DM Hawkins JA Garrett B Stephenson, Stat Med 2001 20 1987 2001 10.1002/sim.819 11427955
20. Discrepant analysis: how can we test a test? AJ McAdam, J Clin Microbiol 2000 38 2027 9 10834948
21. Analysis of correlated ROC areas in diagnostic testing. HH Song, Biometrics 1997 53 370 82 10.2307/2533123 9147602
22. Insights into latent class analysis of diagnostic test performance. MS Pepe H Janes, Biostatistics 2007 8 474 484 10.1093/biostatistics/kxl038 17085745
23. Latent class analysis in chronic disease epidemiology. J Kaldor D Clayton, Stat Med 1985 4 327 35 10.1002/sim.4780040312 3877331
24. Latent class model diagnosis. ES Garrett SL Zeger, Biometrics 2000 56 1055 67 10.1111/j.0006-341X.2000.01055.x 11129461
25. Methods for evaluating the performance of diagnostic tests in the absence of a gold standard: a latent class model approach. ES Garrett WW Eaton SL Zeger, Stat Med 2000 21 1289 307 10.1002/sim.1105
26. The value of latent class analysis in medical diagnosis. D Rindskopf W Rindskopf, Stat Med 1986 5 21 7 10.1002/sim.4780050105 3961312
27. Latent class analysis of diagnostic agreement. JS Uebersax WM Grove, Stat Med 1990 9 559 72 10.1002/sim.4780090509 2190288
28. The estimation of sensitivity and specificity in colorectal cancer screening methods. SD Walter DJ Frommer RJ Cook, Cancer Detect Prev 1991 15 465 9 1782636
29. Latent variable modeling of diagnostic accuracy. I Yang MP Becker, Biometrics 1997 53 948 58 10.2307/2533555 9290225
30. A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis. M Boelaert S Rijal S Regmi R Singh B Karki D Jacquet F Chappuis L Campino P Desjeux D Le Ray S Koirala P Van der Stuyft, Am J Trop Med Hyg 2004 70 1 72 77 14971701
31. Inflation of sensitivity of cervical cancer screening tests secondary to correlated error in colposcopy. RG Pretorius RJ Kim JL Belinson P Elson YL Qiao, J Low Gen Tract Dis 2006 10 5 9 10.1097/01.lgt.0000192694.85549.3d
32. Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe. SD Womack ZM Chirenje PD Blumenthal L Gaffikin JA McGrath T Chipato E Ngwalle KV Shah, BJOG 2000 107 33 8 10.1111/j.1471-0528.2000.tb11576.x 10645859
33. JK Vermunt J Magidson, Technical Appendix for Latent Gold 3 Belmont, MA: Statistical Innovations Inc 2003
34. Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. Y Qu M Tan MH Kutner, Biometrics 1996 52 797 810 10.2307/2533043 8805757
35. Latent structure models with direct effects between indicators: local dependence model. JA Hagenaars, Sociological Methods and Research 1996 16 379 405 10.1177/0049124188016003002
36. Probit: Latent class analysis with dichotomous or ordered category measures: conditional independence/dependence models. JS Uebersax, Applied Psychological Measurement 1999 23 283 297 10.1177/01466219922031400
37. Model selection and multimodel inference: a practical information-theoretic approach. KP Burnam DR Anderson, New York: Springer-Verlag Second 2002
38. Information theory and an extension of the maximum likelihood principle. H Akaike, Second International Symposium on Inference Theory Budapest: AkádmiaiKiadó, Petrov BN, Csáki F, 1973 267 281
39. Screening test accuracy studies: how valid are our conclusions? Application to visual inspection methods for cervical screening. C Mahe L Gaffikin, Cancer Causes and Control 2005 16 657 6 10.1007/s10552-005-0296-4
40. Training for cervical cancer prevention programs in low-resource settings: Focus on visual inspection with acetic acid and cryotherapy. PD Blumenthal M Lauterbach JW Sellors R Sankaranarayanan, Int J Gynecol Obstet 2005 89 Suppl 2 S30 S37 10.1016/j.ijgo.2005.01.012
41. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. R Sankaranarayanan BM Nene KA Dinshaw C Mahe K Jayant SS Shastri R Chinoy R Kelkar AM Budukh V Keskar R Rajeshwarker R Muwonge S Kane DM Parkin, Int J Cancer 2005 116 617 23 10.1002/ijc.21050 15818610
42. Estimation of test sensitivity and specificity when disease confirmation is limited to positive results. SD Walter, Epidemiology 1999 10 67 72 10.1097/00001648-199901000-00012 9888282
43. Assessment of diagnostic tests when disease verification is subject to selection bias. CB Begg RA Greenes, Biometrics 1983 39 207 15 10.2307/2530820 6871349
44. Meta-analysis of diagnostic tests with imperfect reference standards. SD Walter L Irwig PP Glasziou, J Clin Epidemiol 1999 52 943 51 10.1016/S0895- 4356(99)00086-4 10513757
45. Clinical applications of HPV testing: a summary of meta-analyses. M Arbyn P Sasieni CJLM Meijer C Clavel G Koliopoulos J Dillner, Vaccine 2006 24 78 89 10.1016/j.vaccine.2006.05.117
46. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. J Cuzick C Clavel KU Petry CJ Meijer H Hoyer Ratnam A Szarewski P Birembaut S Kulasingam P Sasieni T Iftner, Int J Cancer 2006 119 1095 101 10.1002/ijc.21955 16586444
47. Assessment of innovative approaches to cervical cancer screening, follow-up and treatment of screen detected cervical lesions in developing countries: a pooled analysis of ACCP trial results. M Arbyn L Gaffikin R Sankaranarayanan R Muwonge N Keita R Wesley V Tsu, IPH/EPI-REPORTS Seattle, Brussels, PATH & IPH 2005 2 1 125
48. Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicentre study in India. R Sankaranarayanan R Chatterji SS Shastri P Basu C Mahé R Muwonge D eigneurin S Thara C Roy R Kelkar R Chinoy K Dinshaw R Mandal G Amin S Goswami S Pal S Patil N Dhakad L Frappart B Fontanière, Int J Cancer 2004 112 341 7 10.1002/ijc.20396 15352050
49. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. L Kuhn L Denny A Pollack A Lorincz RM Richart TC Wright, J Natl Cancer Inst 92 10 818 25 2000 May 17 10.1093/jnci/92.10.818 10814677
50. Operator variability in disease detection and grading by colposcopy in patients with mild dysplastic smears. M Sideri F Schettino L Spinaci N Spolti P Crosignani, Cancer 1995 76 1601 5 10.1002/1097-0142(19951101)76:9<1601::AID- CNCR2820760916>3.0.CO;2-Z 8635064
51. Use of colposcopically directed, four-quadrant cervical biopsy by the colposcopy trainee. HD Homesley VW Jobson RL Reish, J Reprod Med 1984 29 311 63 6726700
52. The role of colposcopy in modern gynecology. S Dexeus M Cararach D Dexeus, Eur J Gynaecol Oncol 2002 23 269 77 12214721
53. Cost-effectiveness of cervical-cancer screening in five developing countries. SJ Goldie L Kuhn L Denny A Pollack TC Wright, N Engl J Med 2005 353 20 2158 68 10.1001/jama.285.24.3107 11427139
54. MS Pepe, The Statistical Evaluation of Medical Tests for Classification and Prediction Oxford: Oxford University Press 2003
55. MW Nyankomo M Arbyn T Burzykowski, Impact of imperfect reference tests on the evaluation of the accuracy of new cervical cancer screening tests applied in developing countries. Adjustment for gold standard misclassification using latent class modelling Thesis for MSc in Biostatistics, University of Hasselt (Belgium) 2006
56. Using a combination of reference tests to assess the accuracy of a new diagnostic test. T Alonzo MS Pepe, Statistics in Medicine 1999 18 2987 3003 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.0.CO;2-B 10544302
57. Evaluation of diagnostic tests without gold standards. S Hui XH Zhou, Statistical Methods in Medical Research 1998 7 354 370 10.1191/ 096228098671192352 9871952
58. Cervical cancer control in developing countries: memorandum from a WHO meeting. World Health Organization, Bull World Health Organ 1996 74 345 51 8823955